Table 2.

CAD patients’ therapy characteristics.

	INOCA	Obstructive CAD	p-Value
ACE inhibitors	9 (45.0)	27 (62.8)	0.184
ARB II	6 (30.0)	10 (23.3)	0.567
Beta-blocker	17 (85.0)	34 (79.1)	0.737
Calcium channel blockers	11 (55.0)	18 (41.9)	0.33
Antiaggregants	16 (80.0)	40 (93.0)	0.195
Antiarrhythmic drugs	3 (10.3)	6 (20.0)	0.237
HMG-CoA reductase inhibitors	19 (95.0)	44 (100.0)	0.323
Anticoagulants	4 (15)	6 (13.6)	1.000

ACE inhibitors—angiotensin-converting enzyme inhibitors; ARB II—angiotensin II receptor blockers.